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Abstract
Background: Patients with pre-eclampsia and eclampsia constitute a special high risk group for future
hypertension. They require a long term follow up to be able to detect and treat emerging hypertension
early enough to prevent complications. Unfortunately, this is not so. This study was undertaken to find
out the incidence of history of pre-eclamptic toxaemia (PET) in our female hypertensive patients
attending cardiac clinic and to also determine the incidence of complications of hypertension in those
with previous history of PET.
Methods: Fifty consecutive female hypertensive patients seen in cardiac clinic were recruited. Detailed
history including full obstetric and family history was taken. A full clinical examination was done
including blood pressure and a search for complications of hypertension. Findings were then analyzed
and various frequencies determined.
Results: Forty-nine patients were studied. The mean age was 47.29 ± 11.46 years. The mean SBP, DBP
and MAP were 143.18 ± 25.05, 90.49 ± 14.19 and 108.12 ± 16.71mmHg respectively. Between the last
child birth and the time of established hypertension in those who had PET ranged from 3-25 years.
Sixteen, (32.7%) of the 49 patients had history of PET and 7(43.75%) of these 16 patients had
complications of hypertension.
Conclusion: The incidence of history of PET in our female hypertensive patients attending cardiac clinic
is significant (32.7%). Also the 43.8% incidence of complications of hypertension seen in those patients
with history of PET in this study is high. PET patients, therefore, constitute a special risk group for future
hypertension. Therefore collaboration between the Obstetricians and the Cardiologists is important for
patients with PET and eclampsia.
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Résume
Contexte: Les patientes ayant une toxémie gravidique ou une éclampsie sont un groupe à haut risque
d’hypertension ultérieure. Elles nécessitent un suivi a long terme afin de détecter et traiter une
hypertension émergente suffisamment tôt afin de prévenir les complications. Cela ne se passe
malheureusement pas ainsi. Cette étude a été initiée afin de déterminer l’incidence des antécédents de
toxémie gravidique chez nos patientes hypertendues consultant à la clinique de cardiologie. Il s’agissait
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également de déterminer l’incidence des complications hypertensive chez celles présentant un
antécédent de toxémie gravidique.
Méthode: Nous avons recrute de manière consécutive cinquante patientes hypertendues reçues a la
clinique de cardiologie. L’histoire de la maladie a été détaillée en insistant sur les antécédents
obstétricaux et familiaux. Un examen clinique complet a été effectue incluant la mesure de la pression
artérielle et la recherche de complications de l’hypertension.les données recueillies ont été ensuite
analysées et les différentes fréquences déterminées.
Résultats: Quarante neuf patientes ont été étudiées. L’âge moyen était de 47,29±11,46 ans. Les
moyennes de pression artérielle systolique, diastolique et moyenne étaient respectivement de
143,18±25,05 ; 90,49±14,19 and 108,12±16,71mmHg. Le délai entre le dernier accouchement et le
diagnostic d’hypertension chez celles qui avaient un antécédent de toxémie gravidique s’étendait de 3 a
25 ans. Seize (32,7%) des 49 patientes avaient un antécédent de toxémie gravidique et 7 (43,75%) ;
parmi eux 16 ont eu des complications hypertensives.
Conclusion: L’incidence des antécédents de toxémie gravidique chez nos patientes hypertendues
consultant a la clinique de cardiologie est significative (32,7%). L’incidence de complications
hypertensive (43,8%) observée dans le groupe de patientes ayant un antécédent de toxémie gravidique
dans cette étude est élevée. Les patientes présentant une toxémie gravidique constituent de ce fait un
groupe particulier à risque pouvant développer une hypertension artérielle. La collaboration entre
obstétriciens et cardiologues est de ce fait importante pour les patients ayant une toxémie gravidique
et une éclampsie.
Mots clés: Toxémie gravidique, incidence, hypertension, complications
Introduction
Hypertension remains the commonest non-
communicable disease in Nigeria.
1
If untreated, it can
lead to complications such as congestive heart
failure, cerebrovascular accident, renal disease,
retinopathy, ischemic heart disease etc. However,
effective treatment of hypertension has been
associated with over 50% reduction in heart failure,
35%-45% reduction in stroke and 20%-25% reduction
in myocardial infarction.
2-4
It has been reported that as many as 10% of first
pregnancies in previously normotensive women,
hypertension appears after 20 weeks i.e., gestational
hypertension, and may progress to pre-eclampsia
when the hypertension is complicated by proteinuria,
edema, or hematological or hepatic abnormalities or




predating pregnancy have an even higher incidence
of preclampsia.
6
The long term prognosis of women with
gestational hypertension is said to be excellent.
7
Nonetheless, when compared with women who were
normotensive, the overall prognosis for women who
had hypertension during pregnancy is not as good,
probably because of causes other than pre-
eclampsia, including unrecognized chronic primary
hypertension.
8
After delivery, transient or persistent
hypertension may develop in the mother. In many,
early primary hypertension may have been masked
by the early hemodynamic changes of pregnancy. In a
setting where adequate follow up of these patients,
even long after stopping delivery is non-existent, the
risk of developing complications of hypertension is
high.
The aim of this study is to find out the incidence
of history of PET in our female hypertensives
attending cardiac clinic and also the incidence of
complications of hypertension in these patients with
past history of PET. It will help to fashion out a better
follow up strategy that will lead to early detection
and intervention of any emerging hypertension.
Patients and Methods
Fifty consecutive adult female hypertensive patients
seen at the Cardiac Clinic of Ahmadu Bello University
Teaching Hospital (ABUTH), Zaria, Nigeria were
recruited into the study after due clearance from the
Ethical Committee of Ahmadu Bello University
Hospital and Informed Consent obtained from the
patients. The demographic and clinical characteristics
of these patients were taken from history and
physical examination. Details in the history included
age, parity, last childbirth, (LCB), tribe, whether pre-
menopausal or post-menopausal, number of
pregnancies associated with PET or its symptoms,
evidence of prepregnancy hypertension and
hypertension in pregnancy. Others include history of
diabetes mellitus, antenatal care, peripartum cardiac
failure, number of years post-stopping delivery
patient became hypertensive. Family history of
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hypertension, stroke, congestive cardiac failure (CCF),
sudden death, overweight or obesity, diabetes
mellitus were also asked. History of PET was
accepted if in addition to history of body swelling and
raised blood pressure in pregnancy there was a
documented evidence of PET in the antenatal
records.
All the patients were physically examined with
particular attention paid to the weight, height,
current blood pressure (BP), pulse and the presence
of complications of hypertension such as congestive
cardiac failure (CCF), Hypertensive heart disease
(HHD), cerebrovascular accident (CVA) etc. Urinalysis
was done on these patients to detect if there was
proteinuria or glycosuria.
All information gathered was entered into a
proforma from where it was prepared for data
analysis.
Data analysis
Data analysis was done using SPSS 11.5 Statistical
package. All values were reported as
means ± standard deviation where applicable and
percentages to non-quantitative data. Student t test
was used to determine statistical significance where
necessary. A p value of 0.05 or less was considered
significant.
Results
Forty nine (49) patients out of the initial fifty
recruited were studied. One patient was excluded
because of data mix-up and could not be recalled for
fresh assessment.
Table 1 shows the demographic and clinical
characteristics of the patients. At the time of study,
majority of the patients were in their middle age
brackets and blood pressure still in the hypertensive
range despite treatment.
Table 2 shows family history profile of the
subjects in the entire group. It took 0.25-38 years
(mean, 11.4 ± 8.79 years) after stopping delivery to
develop hypertension in the entire group. Those who
had PET in their pregnancy took 3-25 years (mean.
8.42 ± 7.69 years) to develop hypertension while
those without PET had a mean of 12.76 ± 8.90 years
to develop hypertension. There was no statistically
significant difference between those with PET and
those without.
Thirty five (35) of the patients had records of their
tribal origin. Of this number, 27 (77.1%) were Hausas
and 8(22.9%) were from other tribes in the country.
The preponderance of Hausa patients is due to the
location of our center in Hausa dominated region.
A total of 34 patients had antenatal care (ANC) in
all their pregnancies, 9 in some of their pregnancies
and 6 in none of their pregnancies. All the 16 patients
(Table 3) who had PET in their pregnancies had ANC
in the hospital.
At the time of this study, 27 patients were in the
pre-menopausal period and 22 in the
postmenopausal period. Thirteen (48.1%) of those in
the pre-menopausal period had PET while 3(13.6%)
of those in the postmenopausal period had PET.
Table 3 shows the incidence of history of PET in
the 49 consecutive hypertensive female subjects
seen at the Cardiac Clinic of ABUTH, Zaria. This
incidence of 32.7% is significant.
Table 4 shows the incidence of complications of
hypertension in the studied subjects. In those who
had history of PET the complication rate was 43.8%
which is significant.
Table 1. Clinical and demographic characteristics of patients
Parameter Range Mean ± SD




SBP (mmHg) 100-220 143.18 ± 25.05
DBP (mmHg) 60-130 90.49 ± 14.19
MAP (mmHg) 73-160 108.12 ± 16.71
Pulse pressure (mmHg) 20-94 53.43 ± 16.92
Parity 0-15 6.19 ± 3.77
LCB (years) 0-40 12.56 ± 9.67
BMI = Body mass index, SBP = Systolic blood pressure, DBP = Diastolic blood pressure, MAP = Mean arterial pressure,
LCB = Last child birth
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Table 2. Family history profiles of the 49 subjects studied
Positive family history No. (%) No. with PET (%) No. without PET (%)
Hypertension 25(51) 9(18.3) 16(32.7)
Stroke 6(12.2) 3(6.1) 3(6.1)
CCF 4(8.2) 2(4.1) 2(4.1)
Sudden cardiac death 2(4.1) 1(2.0) 1(2.0)
Obesity 19(38.8) 7(14.3) 12(24.5)
Diabetes Mellitus 6(12.2) 1(2.0) 5(10.2)
CCF = Congestive cardiac failure, PET = Pre-eclamptic toxaemia
Table 3. Incidence of history of pet in
hypertensive female subjects seen in cardiac
clinic of ABUTH, Zaria, Nigeria
Subjects No. (%)
With PET 16 (32.7)
Without PET 33 (67.3)
Total 49 (100)
PET = Pre-eclampsia toxaemia
Table 4. Incidence of complications of
hypertension seen in the study subjects
Subjects (n = 49) No. (%)
No hypertension complications 27 (55.1)







Complications seen were hypertensive heart disease
10(20.4%), hypertensive heart failure 7(14.3%),
cerebrovascular accident 3(6.1%) and peripartum cardiac
failure (PPCF) 2(4.1%), PET = pre-eclamptic toxaemia
Discussion
It is generally agreed that women who have had
severe pre-eclampsia or eclampsia are prone to
hypertension in later life. Young women who develop
pre-eclampsia or eclampsia in their first pregnancy
may have normal pregnancies subsequently, until
they reach 40 or so, when they often develop
hypertension.
9
Older patients on the other hand, who
develop pre-eclampsia for the first time after
previously normal pregnancies, are likely to have
persistent hypertension thereafter.
9
In this study, the
majority of the patients including those who had PET
were already in the fifth decade of life, a period
where hypertension is most prevalent.
10,11
In those
patients who had PET in pregnancy, it took a latent
period of between 3-25 years (mean,8.42 ± 7.69
years) to develop hypertension. The fact that it can
take as long as 25 years to become hypertensive
emphasizes the need to follow up these patients on a
long term basis if early detection of hypertension and
hence, prevention of its complications must be
achieved.
A significant proportion (32.7%) of our female
hypertensive subjects had history of PET (Table 3).
This incidence compares with the work of North RA
et al who in a study of 50 Samoan women with past
pre-eclampsia found that 40% of them were
hypertensive at follow-up compared to 2% in the
control group.
12
The high rate (43.8%) of hypertension
complications seen in these patients may be due to
several factors. First, the time for doctor- patient
interaction is usually too short for adequate patient
education on this subject. This is as result of the gross
disproportion between the number of patients and
the number of doctors available.
Second, due to ignorance, patients still shy away
from regular clinic follow up even after the need for
it has been explained to them by the doctor. They
still hold on tenaciously to the wrong notion that only
when they have symptoms they go to the hospital.
Hypertension is, of course, symptomless unless there
are complications. The magnitude of this problem is
heightened in a setting like ours where the culture of
routine medical checkup is not practiced.
The high level of poverty especially in our area of
clinical practice is another consideration. Most of
these patients are Hausa-Fulani from the villages
scattered around Zaria. They are mostly poor farmers
who may not afford the ‘luxury’ of frequent hospital
visits due to cost of transportation, more so, when
they don’t have symptoms.
In conclusion, the incidence of history of PET
among the female hypertensives attending our
cardiac clinic is quite significant. The incidence of
complications of hypertension in the patients with
history of PET is also high. Several factors ranging
from patients ignorance, poverty to inadequate
patient-doctor interaction may be responsible.
The fact that some of these PET patients are
never seen again in the hospital after discharge
except when they develop complications of
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hypertension calls for better follow up measures
including referrals to primary health care centers
which may be closer to them for regular BP
measurements. A great deal of collaboration
between the obstetricians and the cardiologists is
required so that PET patients are not lost to follow up
only to reappear later with hypertension and its
complications. If this is implemented, early detection
and treatment of emerging hypertension will be
possible in this special group of patients leading to
reduction/prevention of hypertension complications.
This is a hospital based study with a small sample
size. Further studies on this subject using a larger
sample size are therefore recommended.
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